title: Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.
abstract: The development of novel immune adjuvants is emerging as a significant area of vaccine delivery based on the continued necessity to amplify immune responses to a wide array of new antigens that are poorly immunogenic. This article specifically focuses on the application of nanoparticles and microparticles as vaccine adjuvants. Many investigators are in agreement that the size of the particles is crucial to their adjuvant activities. However, reports on correlating the size of particle-based adjuvants and the resultant immune responses have been conflicting, with investigators on both sides of the fence with impressive data in support of the effectiveness of particles with small sizes (submicron) over those with larger sizes (micron) and vice versa, while other investigators reported data that showed submicron- and micron-sized particles are effective to the same degree as immune adjuvants. We have generated a list of biological, immunological and, more importantly, vaccine formulation parameters that may have contributed to the inconsistency from different studies and made recommendations on future studies attempting to correlate the size of particulate adjuvants and the immune responses induced. The information gathered could lead to strategies to optimize the performance of nano-microparticles as immune adjuvants.
authors.affiliation: Department of Pharmaceutical Sciences, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, Rootstown, OH 44272, USA. moyewumi@neoucom.edu
authors.forename: Moses O
authors.initials: MO
authors.lastname: Oyewumi
authors.forename: Amit
authors.initials: A
authors.lastname: Kumar
authors.forename: Zhengrong
authors.initials: Z
authors.lastname: Cui
mesh_terms: D056704:Adaptive Immunity; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D007113:Immunity, Innate; D008863:Microspheres; D053758:Nanoparticles; D010316:Particle Size; D014612:Vaccines / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D014612:Vaccines
references.citation: Pharm Res. 2008 Mar;25(3):551-62
references.pmid: 17912489
references.citation: J Pharm Pharmacol. 2006 Jun;58(6):717-28
references.pmid: 16734973
references.citation: J Control Release. 2000 Jul 3;67(2-3):347-56
references.pmid: 10825566
references.citation: J Pharm Pharmacol. 2005 Jun;57(6):699-707
references.pmid: 15969924
references.citation: Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47
references.pmid: 12628320
references.citation: Pharm Res. 2001 May;18(5):709-12
references.pmid: 11465430
references.citation: J Biomed Mater Res. 2002 Jun 5;60(3):480-6
references.pmid: 11920673
references.citation: Curr Opin Immunol. 2000 Aug;12(4):456-63
references.pmid: 10899018
references.citation: Int J Pharm. 2002 Feb 21;233(1-2):239-52
references.pmid: 11897428
references.citation: Int J Pharm. 2005 Aug 11;299(1-2):155-66
references.pmid: 15998569
references.citation: Vaccine. 2004 Jun 23;22(19):2406-12
references.pmid: 15193402
references.citation: Pharm Res. 2004 Apr;21(4):671-4
references.pmid: 15139524
references.citation: Vaccine. 2000 Dec 8;19(9-10):1047-54
references.pmid: 11137238
references.citation: J Control Release. 2005 Feb 2;102(2):313-32
references.pmid: 15653154
references.citation: Vaccine. 2009 Jun 2;27(27):3643-9
references.pmid: 19464545
references.citation: J Aerosol Med. 2004 Summer;17(2):174-85
references.pmid: 15294069
references.citation: Int J Pharm. 2009 Sep 8;379(1):41-50
references.pmid: 19524654
references.citation: Drug Discov Today. 2008 Oct;13(19-20):882-7
references.pmid: 18656548
references.citation: Int J Pharm. 2008 Apr 2;353(1-2):131-8
references.pmid: 18162346
references.citation: J Immunol. 1997 Mar 15;158(6):2723-30
references.pmid: 9058806
references.citation: J Pharm Sci. 2006 Dec;95(12):2738-50
references.pmid: 16927245
references.citation: Am J Med. 2005 Oct;118 Suppl 10A:7S-15S
references.pmid: 16271535
references.citation: Int J Pharm. 2008 Dec 8;364(2):265-71
references.pmid: 18662761
references.citation: Pharm Res. 2003 Feb;20(2):212-20
references.pmid: 12636159
references.citation: Immunol Rev. 1997 Apr;156:199-209
references.pmid: 9176709
references.citation: Pharm Res. 2001 Mar;18(3):352-60
references.pmid: 11442276
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8578-83
references.pmid: 8710913
references.citation: Methods. 2006 Sep;40(1):1-9
references.pmid: 16997708
references.citation: Biomaterials. 2009 Feb;30(5):879-91
references.pmid: 19027152
references.citation: J Control Release. 2010 Apr 19;143(2):207-14
references.pmid: 20074597
references.citation: Expert Rev Vaccines. 2003 Apr;2(2):269-83
references.pmid: 12899577
references.citation: Cancer Res. 1993 Aug 15;53(16):3765-70
references.pmid: 8339289
references.citation: Biotechnol Prog. 2008 Jul-Aug;24(4):807-14
references.pmid: 19194892
references.citation: J Anat. 1996 Dec;189 ( Pt 3):503-5
references.pmid: 8982823
references.citation: Vaccine. 2003 Feb 14;21(9-10):883-90
references.pmid: 12547598
references.citation: J Pharm Sci. 2009 Mar;98(3):812-43
references.pmid: 18661544
references.citation: J Pharm Sci. 1986 Apr;75(4):361-4
references.pmid: 3723356
references.citation: Int J Pharm. 2006 Mar 27;311(1-2):203-8
references.pmid: 16413708
references.citation: Methods. 2006 Sep;40(1):30-8
references.pmid: 16997711
references.citation: Bioconjug Chem. 1998 Jul-Aug;9(4):418-50
references.pmid: 9667945
references.citation: Vaccine. 1996 Oct;14(15):1442-50
references.pmid: 8994320
references.citation: Nat Rev Immunol. 2006 Feb;6(2):148-58
references.pmid: 16491139
references.citation: J Control Release. 2002 May 17;81(1-2):173-84
references.pmid: 11992690
references.citation: J Microencapsul. 1998 Jan-Feb;15(1):107-19
references.pmid: 9463812
references.citation: Vaccine. 2008 May 23;26(22):2680-8
references.pmid: 18430493
references.citation: Expert Rev Vaccines. 2009 May;8(5):547-57
references.pmid: 19397412
references.citation: Vaccine. 1996 Sep;14(13):1251-6
references.pmid: 8961514
references.citation: Vaccine. 1996 Nov;14(16):1523-30
references.pmid: 9014294
references.citation: Vaccine. 1996 Dec;14(17-18):1677-85
references.pmid: 9032899
references.citation: Biomacromolecules. 2005 May-Jun;6(3):1375-9
references.pmid: 15877355
references.citation: J Control Release. 1998 Dec 4;56(1-3):63-73
references.pmid: 9801430
references.citation: J Microencapsul. 2004 Dec;21(8):829-39
references.pmid: 15799539
references.citation: Trends Immunol. 2009 Jan;30(1):23-32
references.pmid: 19059004
references.citation: Nat Biotechnol. 2007 Oct;25(10):1159-64
references.pmid: 17873867
references.citation: J Immunol. 2004 Nov 15;173(10):6143-50
references.pmid: 15528351
references.citation: Eur J Pharm Biopharm. 2003 Jan;55(1):115-24
references.pmid: 12551712
references.citation: Biomacromolecules. 2009 Mar 9;10(3):651-7
references.pmid: 19203184
references.citation: Curr Drug Deliv. 2008 Oct;5(4):230-42
references.pmid: 18855591
references.citation: Eur J Pharm Sci. 2009 Nov 5;38(4):362-9
references.pmid: 19733658
references.citation: Biomaterials. 2007 Dec;28(35):5344-57
references.pmid: 17825905
references.citation: Int J Pharm. 2010 Jun 30;393(1-2):197-202
references.pmid: 20416366
references.citation: J Virol. 2001 Oct;75(19):9037-43
references.pmid: 11533167
references.citation: Hum Vaccin. 2008 Jan-Feb;4(1):44-9
references.pmid: 18438105
references.citation: Curr Opin Microbiol. 2010 Feb;13(1):106-12
references.pmid: 20079678
references.citation: Int J Pharm. 2005 Mar 3;291(1-2):79-86
references.pmid: 15707734
references.citation: Mol Pharm. 2007 Jan-Feb;4(1):73-84
references.pmid: 17274665
references.citation: J Control Release. 2001 Sep 11;76(1-2):149-68
references.pmid: 11532321
references.citation: Crit Rev Ther Drug Carrier Syst. 1995;12(1):1-99
references.pmid: 8521523
references.citation: Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):518-31
references.pmid: 19941919
references.citation: J Control Release. 2006 May 1;112(1):26-34
references.pmid: 16529839
references.citation: Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):811-6
references.pmid: 10639162
references.citation: Pharm Res. 2002 Feb;19(2):132-9
references.pmid: 11883639
references.citation: Nat Rev Drug Discov. 2003 Sep;2(9):727-35
references.pmid: 12951579
references.citation: Pharm Res. 2002 Jul;19(7):939-46
references.pmid: 12180545
references.citation: Int J Pharm. 2005 Sep 14;301(1-2):149-60
references.pmid: 16023313
references.citation: Pharm Res. 1998 Feb;15(2):270-5
references.pmid: 9523314
references.citation: Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):378-93
references.pmid: 19922750
references.citation: Immunol Cell Biol. 2004 Oct;82(5):488-96
references.pmid: 15479434
references.citation: Vaccine. 2008 Feb 26;26(9):1214-27
references.pmid: 18243435
references.citation: Vaccine. 2002 Nov 22;21(1-2):67-77
references.pmid: 12443664
references.citation: Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):165-96
references.pmid: 11311991
references.citation: Biologicals. 2009 Jun;37(3):141-7
references.pmid: 19285425
references.citation: Biomaterials. 1997 Feb;18(4):327-35
references.pmid: 9068895
references.citation: Adv Drug Deliv Rev. 1998 Dec 1;34(2-3):305-320
references.pmid: 10837683
references.citation: Vaccine. 2007 May 10;25(19):3752-62
references.pmid: 17336431
references.citation: Int J Pharm. 2008 Dec 8;364(2):272-80
references.pmid: 18555624
references.citation: Biomacromolecules. 2005 Sep-Oct;6(5):2590-600
references.pmid: 16153096
references.citation: Adv Drug Deliv Rev. 2008 May 22;60(8):915-28
references.pmid: 18325628
references.citation: Methods. 2006 Sep;40(1):20-9
references.pmid: 16997710
references.citation: J Immunol. 2004 Sep 1;173(5):3148-54
references.pmid: 15322175
references.citation: J Control Release. 2010 Jan 4;141(1):93-100
references.pmid: 19729045
references.citation: J Immunol Methods. 2009 Aug 31;348(1-2):1-8
references.pmid: 19545572
references.citation: J Control Release. 2010 Jun 1;144(2):118-26
references.pmid: 20156497
references.citation: Eur J Immunol. 2008 May;38(5):1404-13
references.pmid: 18389478
references.citation: Vaccine. 2005 Dec 1;23(48-49):5599-617
references.pmid: 16099080
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):870-5
references.pmid: 19139407
references.citation: Trends Biotechnol. 2000 May;18(5):203-11
references.pmid: 10758515
references.citation: Vaccine. 2003 Mar 7;21(11-12):1250-5
references.pmid: 12559806
references.citation: Expert Rev Vaccines. 2007 Jun;6(3):391-400
references.pmid: 17542754
references.citation: Int J Pharm. 2005 Jul 25;298(2):315-22
references.pmid: 15961266